News of Note—Emergent BioSolutions and GeoVax

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Emergent BioSolutions filed for an FDA emergency use authorization for its anthrax vaccine NuThrax. Release

> GeoVax teamed up with Enesi Pharma to develop vaccines on a needle-free delivery platform. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Suggested Articles

An FDA panel gave Sanofi's Dengvaxia a mixed endorsement, voting down its use in people 17 and older.

Prosecutors in the Philippines have found probable cause to indict six Sanofi officials for its Dengvaxia rollout.

The FDA has issued guidance on continuous manufacturing and is allocating $58 million to move forward advanced manufacturing processes.